Richard I. Eisenstadt - 29 Dec 2023 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role: Chief Financial Officer
Signature: /s/ Richard I. Eisenstadt
Issuer symbol: ALT
Transactions as of: 29 Dec 2023
Net transactions value: -$34,245
Form type: 4
Filing time: 02 Jan 2024, 18:00:20 UTC
Previous filing: 02 Aug 2023
Next filing: 29 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALT	Common Stock, par value $0.0001	Options Exercise	$0	+12,500	+52%	$0.000000	36,335	29 Dec 2023	Direct	F1
transaction	ALT	Common Stock, par value $0.0001	Tax liability	$34,245	-3,044	-8.4%	$11.25	33,291	29 Dec 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALT	Restricted Stock Units	Options Exercise	$0	-12,500	-33%	$0.000000	25,000	29 Dec 2023	Common Stock, par value $0.0001	12,500		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
F2	Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
F3	The RSUs become vested and exercisable over four (4) years with 25% of the shares vesting on December 31, 2022, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.